| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | COLUCID PHARMACEUTICALS ORD | 5,575 | 46,000 | 0.00% | ||
| 2 | ONCOCYTE CORP | 64,102 | 228,000 | 0.00% | ||
| 3 | CERES INC | 1,024,020 | 400,000 | 0.01% | ||
| 4 | NANTKWEST INC COM | 225,000 | 1,400,000 | 0.03% | ||
| 5 | AEGERION PHARMACEUTICALS INC | 1,000,000 | 1,490,000 | 0.03% | ||
| 6 | REGENXBIO INC COM | 200,000 | 1,600,000 | 0.03% | ||
| 7 | CEMPRA INC | 100,000 | 1,649,000 | 0.03% | ||
| 8 | DIMENSION THERAPEUTICS INC | 275,000 | 1,650,000 | 0.03% | ||
| 9 | SAREPTA THERAPEUTICS INC | 100,000 | 1,907,000 | 0.04% | Call | |
| 10 | JUNO THERAPEUTICS INC COM | 50,000 | 1,922,000 | 0.04% | Call | |
| 11 | AGENUS INC | 500,000 | 2,025,000 | 0.04% | Call | |
| 12 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 125,000 | 2,074,000 | 0.04% | ||
| 13 | OPHTHOTECH CORP | 50,000 | 2,552,000 | 0.05% | ||
| 14 | SPARK THERAPEUTICS INCORPORATED | 50,000 | 2,557,000 | 0.05% | ||
| 15 | IRONWOOD PHARMACEUTICALS INC | 216,879 | 2,836,000 | 0.06% | ||
| 16 | CELLDEX THERAPEUTICS INC NEW | 675,000 | 2,963,000 | 0.06% | ||
| 17 | SAGE THERAPEUTICS INC | 100,000 | 3,013,000 | 0.06% | Call | |
| 18 | BIOTIME INC | 1,282,050 | 3,346,000 | 0.07% | ||
| 19 | ACCELERON PHARMA INC | 100,000 | 3,398,000 | 0.07% | ||
| 20 | ULTRAGENYX PHARMACEUTICAL INC COM | 75,000 | 3,668,000 | 0.08% | ||
| 21 | RADIUS HEALTH INCORPORATED COM NEW | 100,000 | 3,675,000 | 0.08% | ||
| 22 | RADIUS HEALTH INCORPORATED COM NEW | 100,000 | 3,675,000 | 0.08% | Call | |
| 23 | CHEMOCENTRYX INC | 900,000 | 4,041,000 | 0.08% | ||
| 24 | AGENUS INC | 1,000,000 | 4,050,000 | 0.08% | ||
| 25 | IGNYTA INC COM | 750,000 | 4,065,000 | 0.08% | ||
| 26 | NEUROCRINE BIOSCIE COM USD0.001 | 95,000 | 4,318,000 | 0.09% | ||
| 27 | BLUEBIRD BIO INC COM | 100,000 | 4,329,000 | 0.09% | Call | |
| 28 | INTELLIA THERAPEUTICS INC | 225,000 | 4,804,000 | 0.10% | ||
| 29 | JD COM INC | 250,000 | 5,308,000 | 0.11% | Call | |
| 30 | CELLECTIS S A | 210,000 | 5,584,000 | 0.12% | ||
| 31 | HORIZON PHARMA PLC | 350,000 | 5,765,000 | 0.12% | ||
| 32 | AVEXIS INC COM | 161,900 | 6,155,000 | 0.13% | ||
| 33 | SPECTRANETICS CORP | 350,000 | 6,549,000 | 0.14% | ||
| 34 | AMICUS THERAPEUTICS INC COM | 1,250,000 | 6,825,000 | 0.14% | ||
| 35 | JUNO THERAPEUTICS INC COM | 200,000 | 7,688,000 | 0.16% | ||
| 36 | SERES THERAPEUTICS INC | 310,000 | 9,006,000 | 0.19% | ||
| 37 | METLIFE INC | 250,000 | 9,958,000 | 0.21% | ||
| 38 | MORGAN STANLEY | 400,000 | 10,392,000 | 0.21% | ||
| 39 | CITIGROUPINC | 250,000 | 10,598,000 | 0.22% | ||
| 40 | US FOODS HLDG CORP | 500,000 | 12,120,000 | 0.25% | ||
| 41 | VERTEX PHARMACEUTICALS INC | 150,000 | 12,903,000 | 0.27% | Call | |
| 42 | ARRAY BIOPHARMA INC | 3,870,000 | 13,777,000 | 0.28% | ||
| 43 | BANK AMER CORP | 1,100,000 | 14,597,000 | 0.30% | ||
| 44 | INTERNATIONAL BUSINESS MACHS | 100,000 | 15,178,000 | 0.31% | Call | |
| 45 | JPMORGAN CHASE & CO | 250,000 | 15,535,000 | 0.32% | Call | |
| 46 | AGIOS PHARMACEUTICALS INC | 375,000 | 15,711,000 | 0.32% | ||
| 47 | TESLA INC | 75,000 | 15,921,000 | 0.33% | ||
| 48 | KITE PHARMA INCORPORATED | 325,000 | 16,250,000 | 0.34% | ||
| 49 | ALNYLAM PHARMACEUTICALS INC | 300,000 | 16,647,000 | 0.34% | Call | |
| 50 | DELPHI AUTOMOTIVE PLC | 275,000 | 17,215,000 | 0.36% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-075939, filed 2016.08.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
